EB-1010 (Enterome)

N/A

Report date: 2022/08/09 17:01:13
NME

Base Information

Drug NameEB-1010 (Enterome)
Drug Alias NameEndoMimics
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInterleukin-10 inducers
TargetsInterleukin-10
Therapy Area/IndicationsFood HypersensitivityInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnterome
China Registration ClassN/A

Develop Information

Active CompaniesNestlé Health Science SpainEnterome
Inactive CompaniesN/A
Active IndicationsFood HypersensitivityInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A